• Explore /
  • Poster
  • / Survival and safety of monosialotetrahexosylganglioside in GI cancer patients with oxaliplatin-induced peripheral neurotoxicity-result from TJMUCH-GI-001 trial.

Survival and safety of monosialotetrahexosylganglioside in GI cancer patients with oxaliplatin-induced peripheral neurotoxicity-result from TJMUCH-GI-001 trial.

Abstract Poster

Authors

null

Zhou Likun

Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy Tianjin Medical University, Tianjin, China

Zhou Likun , Dingzhi Huang , Rui Liu , Hongli Li , Tao Ning Sr., Le Zhang , Shaohua Ge , Ming Bai , Xia Wang , Rubing Han , Yuchong Yang , XinYi Wang , Xinyun Chen , Zhiying Gao , Kaijun Niu , Laizhi Luo , Xi Wu , Ting Deng , Yuanquan Yang , Yi Ba

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Symptoms and Survivorship

Track

Symptom Science and Palliative Care

Sub Track

Palliative Care and Symptom Management

Clinical Trial Registration Number

NCT02486198

Citation

J Clin Oncol 37, 2019 (suppl; abstr 11596)

DOI

10.1200/JCO.2019.37.15_suppl.11596

Abstract #

11596

Poster Bd #

288

Abstract Disclosures

Similar Posters

First Author: Zhou Likun

First Author: Simon J. Crabb

First Author: Mark Hertzberg

First Author: Yu-hong Li